Annetta D. Krebs

机构：AstraZeneca (United States)

发表论文 10 篇 · 总被引 3511 次 · h-index 8

代表论文

• Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2 (2004 · Journal of Clinical Oncology · 被引 1723)
• Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials (2005 · Journal of Clinical Oncology · 被引 609)
• Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer (2010 · Journal of Clinical Oncology · 被引 521)
• Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer (2010 · The Journal of Clinical Endocrinology & Metabolism · 被引 258)
• Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung Cancer (2008 · Journal of Clinical Oncology · 被引 221)
• AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors (2013 · The Oncologist · 被引 109)